Bio-product Technology Research Department, Drug Engineering Division, Chugai Pharmaceutical Co., Ltd., 5-1, Ukima 5-Chome, Kita-ku, Tokyo 115-8543, Japan.
J Biosci Bioeng. 2010 Mar;109(3):274-80. doi: 10.1016/j.jbiosc.2009.09.044. Epub 2009 Oct 14.
Pharmaceutical manufacturing plants can be operated continuously for several months. It is therefore important to use cells with long-term stability for the production of active ingredients. We investigated the reliability and long-term stability of an antibody-producing cell line. A recombinant Chinese hamster ovary (CHO) cell line was cultivated in spinner flasks and reactors, including a practical production-scale reactor (1600 L), for 109 days to produce monoclonal antibodies against the HM1.24 antigen. During cultivation, the cells remained stable and there was an increase in the rate of cell proliferation, yielding viable cells at high density. A decrease in cell-specific productivity was associated with this increase in the rate of cell proliferation. The cells were genetically stable and other measures of cellular function remained consistent throughout the cultivation period.
制药厂可以连续运行数月。因此,使用具有长期稳定性的细胞来生产活性成分非常重要。我们研究了一种生产抗体的细胞系的可靠性和长期稳定性。将一株重组中国仓鼠卵巢(CHO)细胞系在摇瓶和生物反应器中进行培养,包括实际生产规模的生物反应器(1600L),用于生产针对 HM1.24 抗原的单克隆抗体。在培养过程中,细胞保持稳定,细胞增殖率增加,高密度培养出活细胞。细胞比生产率的这种增加与细胞增殖率的增加有关。细胞遗传稳定,整个培养期间细胞功能的其他指标保持一致。